Page last updated: 2024-09-04

cinacalcet and Atherosclerosis

cinacalcet has been researched along with Atherosclerosis in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ari, E; Arikan, H; Asicioglu, E; Celik, E; Demir, H; Eren, Z; Kaya, Y1
Abdalla, S; Block, GA; Chertow, GM; Correa-Rotter, R; Dehmel, B; Drüeke, TB; Floege, J; Goodman, WG; Herzog, CA; Kubo, Y; London, GM; Mahaffey, KW; Moe, SM; Parfrey, PS; Trotman, ML; Wheeler, DC1
Inaba, M1
Fernández Giráldez, ED1
Chudek, J; Kocełak, P; Olszanecka Glinianowicz, M; Zelaźnicka, M1

Reviews

2 review(s) available for cinacalcet and Atherosclerosis

ArticleYear
[Clinical advances in vascular calcification].
    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2008, Volume: 28 Suppl 5

    Topics: Aged; Animals; Atherosclerosis; Calcinosis; Chronic Disease; Cinacalcet; Coronary Artery Disease; Diabetes Complications; Ergocalciferols; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Diseases; Mice; Mice, Knockout; Multicenter Studies as Topic; Naphthalenes; Polyamines; Randomized Controlled Trials as Topic; Renal Artery; Sevelamer; Tomography, Spiral Computed; Tomography, X-Ray Computed; Vascular Diseases

2008
[Cinacalcet therapy and cardiovascular risk in hemodialysis patients].
    Postepy higieny i medycyny doswiadczalnej (Online), 2012, Oct-22, Volume: 66

    Topics: Atherosclerosis; Cardiovascular Diseases; Causality; Cinacalcet; Comorbidity; Disease Progression; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Renal Dialysis; Risk Factors; Vascular Calcification

2012

Trials

1 trial(s) available for cinacalcet and Atherosclerosis

ArticleYear
Effects of cinacalcet on atherosclerotic and nonatherosclerotic cardiovascular events in patients receiving hemodialysis: the EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) trial.
    Journal of the American Heart Association, 2014, Nov-17, Volume: 3, Issue:6

    Topics: Atherosclerosis; Calcimimetic Agents; Cinacalcet; Death, Sudden, Cardiac; Double-Blind Method; Female; Heart Failure; Humans; Hyperparathyroidism, Secondary; Intention to Treat Analysis; Kidney Failure, Chronic; Male; Naphthalenes; Renal Dialysis; Risk Factors; Severity of Illness Index; Time Factors; Treatment Outcome

2014

Other Studies

2 other study(ies) available for cinacalcet and Atherosclerosis

ArticleYear
Cinacalcet may improve oxidative DNA damage in maintenance hemodialysis patients: an observational study.
    International urology and nephrology, 2014, Volume: 46, Issue:9

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Atherosclerosis; Carotid Intima-Media Thickness; Cinacalcet; Deoxyguanosine; DNA Damage; Endothelium, Vascular; Female; Humans; Male; Naphthalenes; Oxidative Stress; Prospective Studies; Renal Dialysis

2014
Importance of abnormal bone metabolism in the acceleration of atherosclerosis in hemodialysis patients.
    Contributions to nephrology, 2015, Volume: 185

    Topics: Atherosclerosis; Bone Resorption; Calcimimetic Agents; Calcium; Cinacalcet; Disease Progression; Humans; Phosphates; Renal Dialysis; Renal Insufficiency, Chronic; Vascular Calcification

2015
chemdatabank.com